Caxton Associates LLP Bio Rad Laboratories, Inc. Transaction History
Caxton Associates LLP
- $2.87 Trillion
- Q1 2025
A detailed history of Caxton Associates LLP transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Caxton Associates LLP holds 2,998 shares of BIO stock, worth $745,512. This represents 0.03% of its overall portfolio holdings.
Number of Shares
2,998Holding current value
$745,512% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding BIO
# of Institutions
462Shares Held
18.9MCall Options Held
12.7KPut Options Held
14.4K-
Vanguard Group Inc Valley Forge, PA1.91MShares$475 Million0.01% of portfolio
-
First Eagle Investment Management, LLC1.57MShares$389 Million0.8% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$386 Million0.01% of portfolio
-
Veritas Asset Management LLP913KShares$227 Million2.52% of portfolio
-
Dimensional Fund Advisors LP Austin, TX877KShares$218 Million0.05% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $6.13B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...